Six-month effects of early treatment with lisinopril and transdermal glyceral trinitrate singly and together withdrawn 6 weeks after acute myocardial infarction: the GISSI-3 trial. J Am Coll Cardiol.

In this randomized controlled trial, in older adults with non-ST-segment elevation myocardial infarction (NSTEMI), invasive ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

A pioneering study by Rentrop et al. 1 showed that intracoronary infusion of streptokinase could achieve rapid recanalization following acute myocardial infarction. The seminal work by DeWood et ...

Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 ...

Stress is one of the main causes of health damage, especially the biggest risk factor for cardiovascular disease, causing ...

Myocardial infarction, commonly known as a heart attack, is a critical cardiovascular event with significant implications and occurs when the blood flow to a part of the heart muscle is obstructed ...

Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is ...

NOVO Nordisk on Wednesday announced that Wegovy (semaglutide injection) is now approved to reduce the risk of non-fatal ...

Inspra (eplerenone tablets; Pfizer, Inc., New York, NY) is an aldosterone blocker that works by binding at the mineralocorticoid receptor. It has some similarities to the potassium-sparing ...

Novo Nordisk announced today that Wegovy® (semaglutide injection) is now approved to reduce the risk of non-fatal myocardial ...